Investor Relations
Rule 26

The information in this website has been disclosed for the purposes of Rule 26 of the AIM Rules for Companies (February 2007) and was last updated on 18th January 2012.

Business Information

Business Description


Incorporation and Operation

Xenetic Biosciences plc is incorporated and registered in the United Kingdom (registration number: 3213174). Its main country of operation is the United Kingdom.

Please follow this link for a copy of the current memorandum and articles of association.

 

Directors


Corporate Governance and Internal Controls

Securities Information

Exchanges and Platforms

Xenetic Biosciences plc's ordinary shares are admitted to trading on AIM.

 

Securities in Issue (as at 09/03/2012)

The number of securities in issue is 407,875,428 ordinary shares of 0.5p

 

Securities Not in Public Hands (as at 09/03/2012)

The percentage of the Company's shares that is not in public hands is 69.94%

 

Significant Shareholders (as at 09/03/2012)

 

 

Restrictions on Transfer

There are no restrictions on the transfer of the Company's shares.

Documentation and Announcements

Admission Document

 

Shareholder Circulars

 

Regulatory Announcements

 

Advisors